Literature DB >> 31546568

Reply: Posterior lenticonus with persistent fetal vasculature.

Sudarshan Khokhar1, Chirakshi Dhull1, Karthikeyan Mahalingam1, Pulak Agarwal1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31546568      PMCID: PMC6786160          DOI: 10.4103/ijo.IJO_900_19

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Sir, We have reported for the first time a rare case of bilateral posterior lenticonus with bilateral persistent fetal vasculature (PFV).[1] Both eyes of the patient have subtle findings suggestive of PFV. If not looked at carefully and specifically, PFV may be missed out. This case adds evidence to existing hypothesis that PFV may have a role in pathogenesis of posterior lenticonus.[12] The case mentioned in the letter[3](“Progressive posterior lenticonus with total lenticular opacity”) is of a child with of posterior lenticonus with total cataract. There is no association of PFV noted. The case is well documented, and diagnosed and managed properly. However, we would like to add a few things. It is difficult to distinguish posterior lenticonus from posterior capsular defect with ultrasonography alone. Performing ultrasound biomicroscopy (UBM) with 35 MHz probe adds valuable information in surgical planning as lens curvature and continuity of posterior capsule can be clearly seen.[45] During surgery, since posterior capsule is thinned out, precautions need to be taken to avoid inadvertent capsule rupture. Gentle hydrodissection, low flow settings and bimanual surgery are recommended[6]“Jellyfish sign” mentioned in the letter is due to anterior and posterior bulging of posterior capsule with change in IOP and flow rate.[7] It may also be seen in cases of posterior capsular defect where anterior hyaloid face is intact. Posterior capsulorhexis can be performed depending on the age and IOL can be implanted in the bag or sulcus based on size of posterior capsulorhexis and area of thinning. With due precautions, complications during surgery are rare and anatomical outcomes are good.[8] Visual outcomes may be affected by presence of amblyopia in long standing cases. Hence, in addition to cataract extraction, emphasis has to be laid on amblyopia therapy post-operatively for visual rehabilitation.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  8 in total

1.  Preoperative usage of ultrasound biomicroscopy in pediatric cataract.

Authors:  Abdullah Kaya
Journal:  Arq Bras Oftalmol       Date:  2016-02       Impact factor: 0.872

2.  Jellyfish sign for intraoperative identification of posterior lenticonus.

Authors:  Sri Ganesh; Sheetal Brar; Kritika Chopra
Journal:  Int Ophthalmol       Date:  2016-10-31       Impact factor: 2.031

3.  Unilateral posterior lenticonus with persistent hyaloid artery remnant.

Authors:  L A Kilty; D A Hiles
Journal:  Am J Ophthalmol       Date:  1993-07-15       Impact factor: 5.258

4.  Intraocular lens implantation in pediatric eyes with posterior lentiglobus.

Authors:  M Edward Wilson; Rupal H Trivedi
Journal:  Trans Am Ophthalmol Soc       Date:  2006

5.  Preoperative considerations and outcomes of primary intraocular lens implantation in children with posterior polar and posterior lentiglobus cataract.

Authors:  Susannah K Mistr; Rupal H Trivedi; M Edward Wilson
Journal:  J AAPOS       Date:  2007-10-29       Impact factor: 1.220

Review 6.  Pediatric cataract.

Authors:  Sudarshan Kumar Khokhar; Ganesh Pillay; Chirakshi Dhull; Esha Agarwal; Manish Mahabir; Pulak Aggarwal
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

7.  Posterior lenticonus with persistent fetal vasculature.

Authors:  Sudarshan Khokhar; Chirakshi Dhull; Karthikeyan Mahalingam; Pulak Agarwal
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

8.  Comment on: Progressive posterior lenticonus with total lenticular opacity.

Authors:  Nirupama Kasturi; Vignesh Elamurugan
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.